40 Participants Needed

Acoustic Stimulation for Depression

(SERS Trial)

ME
Overseen ByMichelle E Stepan, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests whether playing gentle sounds during deep sleep can reduce anxiety and depression symptoms in young adults who struggle with these issues and have trouble sleeping. Participants will spend two nights in a sleep lab, wearing a headband that either plays sounds (acoustic stimulation) or remains silent. Afterward, they will use the headband at home for two weeks, with half of the participants hearing sounds at night and the other half not. The trial suits individuals aged 18-25 who experience high anxiety or depression and have difficulty sleeping. As an unphased trial, this study offers a unique opportunity to explore innovative ways to improve mental health and sleep quality.

Do I need to stop taking my current medications for the trial?

Yes, you will need to stop taking any psychotropic medications or medications affecting sleep/wake function, such as antidepressants, antipsychotic medications, steroids, and stimulants, as these may affect sleep and cognitive-emotional function.

What prior data suggests that this headband device is safe for use in young adults with anxiety and depression?

Research has shown that sound therapy is generally safe. In one study, participants reported no serious side effects during treatment. Another study found that sound therapy not only avoided harmful side effects but also helped reduce stress, depression, and anxiety. Overall, these findings suggest that sound therapy is well-tolerated and safe.12345

Why are researchers excited about this trial?

Researchers are excited about using acoustic stimulation for treating depression because it offers a novel approach by potentially enhancing brain activity during sleep. Unlike standard treatments like antidepressants or psychotherapy, which can take weeks to show results, this method could accelerate the improvement process by directly influencing sleep patterns. This technique is non-invasive, making it a less intrusive option compared to medications or electroconvulsive therapy, and it could provide relief with fewer side effects. By targeting the brain's natural rhythms, acoustic stimulation might offer a quicker and more direct path to alleviating depressive symptoms.

What evidence suggests that this trial's treatments could be effective for depression?

Research has shown that sound therapy, such as the acoustic stimulation studied in this trial, can reduce stress, depression, and anxiety, and improve sleep. In one study, participants who received sound therapy experienced less stress and anxiety and slept better. Another study found that sound therapy significantly improved sleep problems, often linked to mood issues like depression. This trial will explore different sequences of acoustic stimulation and sham treatments to assess their effects on mood and sleep. Sound therapy has also demonstrated benefits for symptoms after a concussion, highlighting its potential for brain health. These findings support the idea that sound therapy could effectively address anxiety and depression.23678

Who Is on the Research Team?

ME

Michelle E Stepan, PhD

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

Young adults aged 18-25 with normal hearing, experiencing anxiety or depression and sleep disturbances can join. They must not use drugs/alcohol before sessions, have extreme sleep schedules, vision issues, claustrophobia, metal in the body, a BMI over 40, severe insomnia/sleep apnea symptoms or be pregnant.

Inclusion Criteria

My sleep quality is poor, scoring 55 or higher on a sleep test.
Elevated anxiety or depression symptoms determined using the PROMIS anxiety and PROMIS depression scales with T-scores ≥ 60
I have normal hearing.

Exclusion Criteria

Short (<5hrs) or long (>9hrs) average sleep duration
Substance abuse
Presence of a severe chronic or psychiatric condition including psychosis, bipolar disorder, developmental disorders, or substance use disorder
See 16 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
Online survey and in-person baseline visit

Baseline and Acclimation

Participants complete baseline assessments and acclimate to the headband device

1 week
1 in-person visit, daily sleep diary entries

Overnight Sessions

Participants undergo two overnight sessions with acoustic stimulation and sham conditions

2 weeks
2 overnight visits

At-home Phase

Participants use the headband device at home for approximately 2 weeks with daily assessments

2 weeks
Daily at-home use and assessments

Follow-up

Participants return for a final testing visit to assess cognitive and emotional processes

1 day
1 in-person visit

What Are the Treatments Tested in This Trial?

Interventions

  • Acoustic Stimulation
  • Daily acoustic stimulation
  • No Acoustic Stimulation
  • No daily acoustic stimulation
Trial Overview The trial tests if acoustic stimulation during sleep affects cognitive-emotional processes in those with anxiety/depression. Participants wear a headband at night that may play tones to enhance slow-wave activity; effects are measured through tasks and self-reports.
How Is the Trial Designed?
4Treatment groups
Experimental Treatment
Group I: Stim, then Sham, then daily StimExperimental Treatment3 Interventions
Group II: Stim, then Sham, then daily ShamExperimental Treatment3 Interventions
Group III: Sham, then Stim, then daily StimExperimental Treatment3 Interventions
Group IV: Sham, then Stim, then daily ShamExperimental Treatment3 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

Michelle Stepan

Lead Sponsor

Trials
1
Recruited
40+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Brain & Behavior Research Foundation

Collaborator

Trials
63
Recruited
2,900+

Published Research Related to This Trial

The MED-EL Electric-Acoustic Stimulation (EAS) System is shown to be a safe and effective treatment for adults with low-frequency hearing and severe-to-profound hearing loss in higher frequencies, with 92% of participants completing the study and 97% able to use the acoustic unit after 12 months.
At 12 months postactivation, 94% of subjects performed as well or better on speech perception tests in noise compared to their preoperative performance, indicating significant improvements in hearing capabilities with the EAS system.
Multicenter US Clinical Trial With an Electric-Acoustic Stimulation (EAS) System in Adults: Final Outcomes.Pillsbury, HC., Dillon, MT., Buchman, CA., et al.[2019]
In a study involving normal volunteers and depressed patients, auditory stimulation during REM sleep significantly increased REM sleep time and sleep efficiency in normal volunteers who received stimulation during each REM episode (Group R).
Depressed patients did not experience increased REM sleep time with auditory stimulation, but they did have shorter REM episodes and more frequent awakenings, indicating that the effects of auditory stimulation may differ based on the individual's mental health status.
Effects of auditory stimulation during rapid eye movement sleep in healthy volunteers and depressed patients.Salin-Pascual, RJ., Granados-Fuentes, D., de la Fuente, JR., et al.[2019]
In a well-conducted trial involving 236 participants with major depression, the Alpha-Stim AID device was found to be safe, with only 7% reporting adverse events, but it did not show any significant clinical effectiveness compared to a sham device.
Both the active and sham groups experienced similar reductions in depression symptoms, indicating that the Alpha-Stim AID device is not more effective than placebo in treating major depression.
Clinical effectiveness of active Alpha-Stim AID versus sham Alpha-Stim AID in major depression in primary care in England (Alpha-Stim-D): a multicentre, parallel group, double-blind, randomised controlled trial.Morriss, R., Patel, S., Boutry, C., et al.[2023]

Citations

Effects of acoustic neurostimulation in healthy adults on ...Notably, participants exhibited decrease in symptoms of stress, depression, and anxiety, coupled with improved sleep quality. These data suggest that alpha ...
Treatments and regulatory mechanisms of acoustic stimuli on ...Acoustic stimuli such as music or ambient noise can significantly affect physiological and psychological health in humans. We here summarize positive ...
A systematic review and meta-analysis of acoustic ...The results showed that acoustic stimulation significantly improved insomnia severity as evidenced by PSQI and ISI scores. Despite no ...
Randomized, controlled clinical trial of acoustic stimulation ...Ten hours of acoustic stimulation while resting in a zero-gravity chair improves postconcussive symptoms.
Quantitative analysis of the effects of acoustic ...To quantitatively analyze the effects of acoustic neurostimulation on the symptoms of depression, anxiety, stress, and sleep quality in healthy workers.
A systematic review and meta-analysis of acoustic ...The results showed that acoustic stimulation significantly improved insomnia severity as evidenced by PSQI and ISI scores. Despite no ...
Acoustic Stimulation, Sleep, and Cognitive-Emotional ...In this study, the investigators will recruit young adults (ages 18-25 years) with elevated anxiety/depression symptoms and sleep disturbance.
Deep transcranial ultrasound stimulation using ...No serious adverse events occurred during the study. By day 5 of treatment, depression severity was reduced by an average of 60.9 % (range: [30 %–83.9 %]), and ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security